States That Have Made Advancements Toward Legalizing Psychedelics

July 13, 2022 14:48:38

Interest in psychedelics has grown significantly as mainstream acceptance grows and research uncovers more of the benefits that these substances possess, including how they can be used to manage a range of mental health disorders. These positive advancements have even led some states to decriminalize these controlled substances, with other states set to legalize the substances in the near future.

Let’s look at some of the states that may soon legalize psychedelics.


In November 2020, the state of Oregon passed a measure that would establish legal psychedelic healing centers where individuals aged 21 and above could undergo psilocybin-assisted therapy.

Since then, the Beaver state has been working on implementing rules to govern these establishments, which may be launched before next year ends.

In addition to this, the state decriminalized the possession of small amounts of any and all illicit substances, psychedelics included.


The Golden State is currently debating the SB-519 bill, which would decriminalize the personal use of psychedelics such as DMT, LSD, MDMA and psilocybin. The measure, if passed, would also permit the supported or facilitated use of psychedelics in therapy centers.

The decriminalization of psychedelics in the state of California would be a big step toward putting an end to the drug war in the country.

New Jersey

Last month, the leader of the state’s Senate filed a measure that would legalize the home cultivation, gifting and possession of psilocybin mushrooms for individuals aged 21 and above.

The measure, known as the Psilocybin Behavioral Health Access and Services Act, would also establish a framework that would permit psilocybin therapy centers to operate, with licensed therapists being allowed to administer psilocybin therapy. The bill’s passage would bring the state of New Jersey one step closer to legalizing these therapeutic substances.


Earlier in May, Connecticut’s governor signed a budget measure that includes a provision to establish psychedelic-assisted treatment centers where eligible patients could receive government-funded MDMA or psilocybin-assisted therapy.

This will all be managed by the Connecticut Psychedelic Treatment Advisory Board, which will be set up once the measure is approved. If the program is a success, access to psychedelic therapy and legalization may soon be actualized.


Residents in the state of Colorado are set to vote on an initiative that would legalize the personal use of natural psychedelics such as DMT and psilocybin during this year’s midterm elections.

The state also plans to establish psilocybin therapy healing centers where individuals aged 21 and above can receive psychedelic-assisted therapy administered by a trained practitioner. This move opens up treatment to any resident in the state, which if successful may positively influence the state’s stance on current psychedelic classification at the local level.

As more reforms are enacted at state level, established companies such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) could have more markets within which to set up shop.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.